@entity1702 ( XXXX ) in Left-Sided @entity694 -a @entity5 Center Experience.

@entity1 @entity5 @entity1702 @entity14 @entity694
BACKGROUND AND STUDY AIMS: @entity1702 ( @entity1702 ) are a surgery-sparing option for malignant @entity694 . They can be inserted as a "bridge to surgery" (BTS) for potentially curable disease, or as a palliative measure, thereby avoiding the higher morbidity and mortality associated with surgery. The objective of this study was to report our local experience of left-sided colonic stents. METHODS: Data on 49 @entity1 was collected retrospectively from Oct 2008 to Nov 2014 at our @entity5 centre. This included demographics, baseline clinical characteristics, indications for @entity1702 placement (bridge to surgery/palliative), technical and clinical success, complications, and the mean patency of duration. Survival in both groups was also plotted on a Kaplan-Meier chart. RESULTS: A total of 49 @entity1 with @entity14 ( @entity14 ) of the left side were enrolled. The mean age was 50  years (range 18-86). Ninety percent of @entity1 had disease involving the rectum, sigmoid colon, or both. Forty-seven percent (n   =   23) of @entity1 had stent insertion as a BTS, whereas 53  % (n   =   26) had the procedure with palliative intent. Technical and clinical success rates were 96  and 88  %, respectively. The clinical success rate of the palliative arm was lower than that of the BTS arm (p   =   0.024). 87.5  % (n   =   42) had no procedure-related complications. Technical failure, perforation, and stent migration/expulsion, were each observed in 4  % of cases. Mean stent patency duration was 83.9  days. CONCLUSION: @entity1702 insertion for left-sided malignant @entity694 is a safe and effective procedure when used either as a bridge to surgery or with palliative intent.
